Pharma Focus Asia

Repligen

LATEST NEWSRead more...

26

Jul 2024

Ractigen Secures FDA Rare Pediatric Disease Designation for RAG-18 in Duchenne Muscular Dystrophy Treatment

Ractigen Therapeutics a leader in small activating RNA therapies has received Rare Pediatric Disease Designation from the US Food and Drug Administration for its saRNA candidate RAG

26

Jul 2024

IASO Bio Secures NMPA Approval to Begin Trials for IASO-782 in Systemic Lupus Erythematosus (SLE)

IASO Biotechnology a company specializing in advanced cell therapy and antibody products has received approval from the National Medical Products Administration for its investigational new drug

26

Jul 2024

A.forall Secures FDA Approval for Fifth Generic Drug Application on First Submission Cycle

Aforalls US subsidiary Milla Pharmaceuticals Inc has introduced its generic version of PrecedexDexmedetomidine Hydrochloride Injection in mcg per mL and mcg per mL formulated

25

Jul 2024

Eisai and EcoNaviSta Forge Business Partnership to Develop a Dementia Care Ecosystem and Initiate Collaboration

Eisai Co Ltd and EcoNaviSta Inc have formed a strategic alliance to tackle dementia a significant challenge in Japans aging population Eisai a leader in dementia research and awareness and EcoNaviSta

25

Jul 2024

Pfizer Reveals Successful Phase 3 Outcomes for Hemophilia A Gene Therapy Candidate

Pfizer Inc has released positive topline results from the Phase AFFINE study which tested giroctocogene fitelparvovec a gene therapy for adults with moderately severe to severe hemophilia A

24

Jul 2024

BeiGene Launches U.S. Biologics Manufacturing and R&D Facility, Advancing Global Expansion to Serve More Patients

BeiGene Ltd a global oncology company has launched its flagship US facility at the Princeton West Innovation Campus in Hopewell NJ This advanced site features cuttingedge biologics

Solovpe

press releasesRead more...

26

Jul 2024

Breakthrough in gene therapy brings new hope to Glaucoma patients

Macquarie University researchers have identified a gene therapy that could help treat the eye disease glaucoma with potential applications for other neurodegenerative conditions such as Alzheimers disease Glaucoma may result in irreversible blindness over to years if left untreated Like Alzheimers...

26

Jul 2024

Bio-Thera Solutions Initiates Integrated Phase I / Phase III Clinical Trial for BAT3306, a Proposed Biosimilar of Keytruda® (Pembrolizumab)

BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that dosing has recently begun in an integrated Phase I

26

Jul 2024

Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology cardiovascular and metabolic

26

Jul 2024

ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally

ObvioHealth a global digital clinical trials company announces a new strategic investment by Guardant Health Inc a leading precision oncology company offering liquid

25

Jul 2024

Bio-Thera Solutions Announces Regulatory Filing Acceptance for BAT2206, a Proposed Biosimilar to Stelara® in the US and EU

BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that the FDA has accepted the BLA for BAT a proposed

25

Jul 2024

COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides

NanoViricides Inc a clinical stage global leader in broadspectrum antiviral nanomedicines today reminds the strong safety and effectiveness against coronaviruses demonstrated by its lead clinical drug candidate

30 - 01

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

30 - 01

Jul 2024

Inalab 2023

Jakarta Barat, Indonesia

13 - 14

Aug 2024

ADVANCING BUSINESS, TECHNOLOGY AND INNOVATION

Songdo Convensia, Incheon, South Korea

13 - 14

Aug 2024

12 YEARS OF EXCELLENCE: SOUTH KOREA’S BIOLOGICS

Songdo Convensia, Incheon, South Korea

19 - 21

Aug 2024
Hexagon - Expert Insights Webinar
MFA + MMA 2024
4th Annual Cleaning Validation 2024
2nd Annual Pharma Impurity Conclave 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Datamonitor

    Analyst

    include the changing patent laws as countries aim to become more TRIPS compliant with India updating its law recently and China in the process of doing so through the WTO Increasing globalization of the generics market with Indian companies becoming involved in Europe and the US and vice versa will also provide an opportunity for generics companies
  • Articles

    A Structured Review on BCRP-Mediated Multidrug Resistance

    Many of the human ABC proteins are efflux transporters and three of them namely Pglycoprotein Pgp gene symbol ABCB the multidrug resistance protein MRP gene symbol ABCC and the breast cancer resistance protein BCRP gene symbol ABCG have been implicated to be the major efflux transporters responsible for multidrug resistance in cancer cells

  • Case Studies

    Isolation Technology: Case Study

    A customer active in the hormone production recently searched an appropriate solution for grinding material and clean packaging after the filtering and drying processThe following requirements had to be metTo provide a safe barrier between the operator and the active drug substance to provide both operator and product protect

  • Techno Trends

    NUS Researchers Develop Novel Microneedle Patch

    A research team led by Dr Kang Lifeng of the Department of Pharmacy at the National University of Singapore NUS Faculty of Science has successfully invented a microneedles patch to let collagen go up to the dermis layer of the skin without any pain and respond fasterThe novel microneedles patch is intended to encapsulate lidocaine a common painkiller or collagen in

EDITORIAL SECTION